North America Sterilization Technologies Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Sterilization Technologies Market size is expected to reach US$ 4,241.5 Million by 2031 from US$ 2,588.4 Million in 2024. The market is estimated to record a CAGR of 7.1% from 2025 to 2031.

Executive Summary and North America Sterilization Technologies Market Analysis:

North America receives significant contributions from the well-developed healthcare infrastructure, strict regulatory frameworks, and high research and development investments. Hospitals and device manufacturers in the US and Canada are under pressure to reduce healthcare-associated infections and ensure the complete lifecycle traceability of sterilized instruments and reusable medical devices. Hospitals are upgrading from traditional steam or ethylene-oxide methods to the rollout of low-temperature sterilization technologies (such as hydrogen-peroxide plasma and ozone systems). At the same time, units of sterilization equipped with real-time data and linked to hospital IT systems to facilitate predictive maintenance, cycle-validation reporting, and instrument tracking are also gaining popularity.

North America Sterilization Technologies Market: Strategic Insights

North America Sterilization Technologies Market Segmentation Analysis:

• By Method, the North America Sterilization Technologies Market is segmented into Ethylene Oxide, Chlorine Dioxide, Gamma Ray, Electron Beam, Autoclave Steam, and Others. The Ethylene Oxide segment dominated the market in 2024.
• By End User, the North America Sterilization Technologies Market is segmented into Medical Device Companies, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Laboratories, and Others. The Medical Device Companies segment dominated the market in 2024.

North America Sterilization Technologies Market Players Density: Understanding Its Impact on Business Dynamics

The North America Sterilization Technologies Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Sterilization Technologies Market Outlook

Hospital-acquired infections (HAIs) are infections that patients get in a healthcare setting during the treatment they receive for other diseases. These infections lead to extended hospital stays and higher healthcare costs. A systematic review and meta-analysis found that HAIs pooled prevalence in low- and middle-income countries was around 22%, and it identified surgical site infections as the most common, accounting for 27% of cases.The development of antibiotic-resistant pathogens, such as multidrug-resistant Gram-negative bacteria, has made the problem of HAIs more challenging to treat. The World Health Organization reported that in 2023, one in six bacterial infections worldwide were antibiotic-resistant, and more than 40% of antibiotics had lost their effectiveness against common infections between 2018 and 2023. Furthermore, antimicrobial resistance necessitates that healthcare systems adhere strictly to infection control protocols, which entail executing proper sterilization procedures. Advanced sterilization technologies such as UV-C disinfection robots, highly efficient air purification systems, and antimicrobial surfaces are being introduced to improve the efficiency of sterilization. Thus, a rising incidence of HAIs is leading to reinforced measures for the prevention of infections in healthcare facilities.

North America Sterilization Technologies Market Country Insights

By country, the North America Sterilization Technologies Market is segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.

The sterilization technologies market in the US is evolving because of regulatory pressure, an increase in surgical volumes, and continuous infection-control measures. One in every 31 patients in hospitals in the US, according to a federal source, acquires a healthcare-associated infection (HAI) at any given time. This statistic highlights the ongoing difficulty in sterilizing reusable instruments and devices.

The market has seen notable developments. In early 2024, the Environmental Protection Agency (EPA) mandated a nearly 90% reduction in ethylene oxide (EtO) emissions from medical device sterilization facilities over a short period, citing cancer risk concerns. As a result of stricter EtO regulations, hospitals and device manufacturers have shifted toward alternative low-temperature sterilization technologies, such as vaporized hydrogen peroxide systems, and adopted digital traceability of sterilization cycles to enhance communication. While hospitals and manufacturers focus on substitution, the equipment and service segment is steadily expanding, particularly within the U.S. sterilization services market in the coming years.

North America Sterilization Technologies Market Company Profiles

Some of the key players operating in the market include Steris Plc, Thermo Fisher Scientific Inc, Amcor Plc, Johnson & Johnson, 3M Co, Getinge AB, Nordion, Belimed, MATACHANA, Noxilizer, Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Sterilization Technologies Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise